FDA approves Soleno’s rare disease drug for Prader-Willi syndromenews2025-03-26T21:09:11+00:00March 26th, 2025|Endpoints News|
Exelixis’ cancer drug wins approval for neuroendocrine tumorsnews2025-03-26T18:29:44+00:00March 26th, 2025|Endpoints News|
Why did radiopharma biotech Actinium hold an investor event at Mar-a-Lago?news2025-03-26T17:05:53+00:00March 26th, 2025|Endpoints News|
J&J touts new survival data for lung cancer combonews2025-03-26T16:01:33+00:00March 26th, 2025|Endpoints News|
Wave strengthens case for accelerated approval, with more positive Duchenne datanews2025-03-26T15:21:33+00:00March 26th, 2025|Endpoints News|
Endpoints Slack interview: Duke’s Chatterjee on AI bio, NIH cutsnews2025-03-26T13:00:51+00:00March 26th, 2025|Endpoints News|
Epicrispr raises $68M, will start clinical trial of epigenetic editing for FSHDnews2025-03-26T12:00:45+00:00March 26th, 2025|Endpoints News|
Senate confirms Marty Makary as 26th FDA commissionernews2025-03-26T00:57:43+00:00March 26th, 2025|Endpoints News|
Axsome reports Phase 3 win for Sunosi in adults with ADHDnews2025-03-25T17:08:11+00:00March 25th, 2025|Endpoints News|
Exclusive: Anti-aging mRNA therapy biotech acquires Harvard startup’s microvesicle delivery technews2025-03-25T15:28:32+00:00March 25th, 2025|Endpoints News|
